rs776091285
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_001035.3(RYR2):āc.12917T>Cā(p.Phe4306Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,613,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001035.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR2 | NM_001035.3 | c.12917T>C | p.Phe4306Ser | missense_variant | 90/105 | ENST00000366574.7 | NP_001026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.12917T>C | p.Phe4306Ser | missense_variant | 90/105 | 1 | NM_001035.3 | ENSP00000355533 | P1 | |
RYR2 | ENST00000660292.2 | c.12938T>C | p.Phe4313Ser | missense_variant | 91/106 | ENSP00000499787 | ||||
RYR2 | ENST00000659194.3 | c.12905T>C | p.Phe4302Ser | missense_variant | 90/105 | ENSP00000499653 | ||||
RYR2 | ENST00000609119.2 | c.*4009T>C | 3_prime_UTR_variant, NMD_transcript_variant | 89/104 | 5 | ENSP00000499659 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248762Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134922
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461542Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 727062
GnomAD4 genome AF: 0.000217 AC: 33AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74322
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 07, 2018 | The F4306S variantin the RYR2 gene has been identified in one individual with arrhythmogenic right ventricular cardiomyopathy (ARVC) (Akdis et al., 2016), and it has been identified in conjunction with additional cardiogenetic variants in one other individual referred for cardiomyopathy genetic testing at GeneDx. However, thus far, segregation data is limited or absent for this individual. The F4306S variant is observed in 7/111,248 (0.006%) alleles from individuals of European (non-Finnish) ancestry in large population cohorts (Lek et al., 2016). The F4306S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Moreover, In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. - |
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 4306 of the RYR2 protein (p.Phe4306Ser). This variant is present in population databases (rs776091285, gnomAD 0.006%). This missense change has been observed in individual(s) with arrhythmogenic ventricular dysplasia/cardiomyopathy (PMID: 26569459). ClinVar contains an entry for this variant (Variation ID: 201186). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RYR2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jan 08, 2019 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 25, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at